Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Charles Natanson Peter Q Eichacker |
| Publication date | January 1, 2003 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |